Cargando…
P688: ASC2ESCALATE: A US PHASE 2, OPEN-LABEL, SINGLE-ARM, DOSE-ESCALATION STUDY OF ASCIMINIB MONOTHERAPY IN 2ND-LINE (2L) TREATMENT OF PATIENTS (PTS) WITH CHRONIC MYELOID LEUKEMIA IN CHRONIC PHASE (CML-CP)
| Autores principales: | , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10428989/ http://dx.doi.org/10.1097/01.HS9.0000969656.81442.84 |
| _version_ | 1785090603402395648 |
|---|---|
| author | Atallah, Ehab Mauro, Michael Sasaki, Koji Yair Levy, Moshe Koller, Paul Sadek, Islam Yang, Daisy Ruckel-Kumar, Julie Khan, Mahmudul Cortes, Jorge |
| author_facet | Atallah, Ehab Mauro, Michael Sasaki, Koji Yair Levy, Moshe Koller, Paul Sadek, Islam Yang, Daisy Ruckel-Kumar, Julie Khan, Mahmudul Cortes, Jorge |
| author_sort | Atallah, Ehab |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10428989 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Lippincott Williams & Wilkins |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-104289892023-08-17 P688: ASC2ESCALATE: A US PHASE 2, OPEN-LABEL, SINGLE-ARM, DOSE-ESCALATION STUDY OF ASCIMINIB MONOTHERAPY IN 2ND-LINE (2L) TREATMENT OF PATIENTS (PTS) WITH CHRONIC MYELOID LEUKEMIA IN CHRONIC PHASE (CML-CP) Atallah, Ehab Mauro, Michael Sasaki, Koji Yair Levy, Moshe Koller, Paul Sadek, Islam Yang, Daisy Ruckel-Kumar, Julie Khan, Mahmudul Cortes, Jorge Hemasphere Posters Lippincott Williams & Wilkins 2023-08-08 /pmc/articles/PMC10428989/ http://dx.doi.org/10.1097/01.HS9.0000969656.81442.84 Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially. |
| spellingShingle | Posters Atallah, Ehab Mauro, Michael Sasaki, Koji Yair Levy, Moshe Koller, Paul Sadek, Islam Yang, Daisy Ruckel-Kumar, Julie Khan, Mahmudul Cortes, Jorge P688: ASC2ESCALATE: A US PHASE 2, OPEN-LABEL, SINGLE-ARM, DOSE-ESCALATION STUDY OF ASCIMINIB MONOTHERAPY IN 2ND-LINE (2L) TREATMENT OF PATIENTS (PTS) WITH CHRONIC MYELOID LEUKEMIA IN CHRONIC PHASE (CML-CP) |
| title | P688: ASC2ESCALATE: A US PHASE 2, OPEN-LABEL, SINGLE-ARM, DOSE-ESCALATION STUDY OF ASCIMINIB MONOTHERAPY IN 2ND-LINE (2L) TREATMENT OF PATIENTS (PTS) WITH CHRONIC MYELOID LEUKEMIA IN CHRONIC PHASE (CML-CP) |
| title_full | P688: ASC2ESCALATE: A US PHASE 2, OPEN-LABEL, SINGLE-ARM, DOSE-ESCALATION STUDY OF ASCIMINIB MONOTHERAPY IN 2ND-LINE (2L) TREATMENT OF PATIENTS (PTS) WITH CHRONIC MYELOID LEUKEMIA IN CHRONIC PHASE (CML-CP) |
| title_fullStr | P688: ASC2ESCALATE: A US PHASE 2, OPEN-LABEL, SINGLE-ARM, DOSE-ESCALATION STUDY OF ASCIMINIB MONOTHERAPY IN 2ND-LINE (2L) TREATMENT OF PATIENTS (PTS) WITH CHRONIC MYELOID LEUKEMIA IN CHRONIC PHASE (CML-CP) |
| title_full_unstemmed | P688: ASC2ESCALATE: A US PHASE 2, OPEN-LABEL, SINGLE-ARM, DOSE-ESCALATION STUDY OF ASCIMINIB MONOTHERAPY IN 2ND-LINE (2L) TREATMENT OF PATIENTS (PTS) WITH CHRONIC MYELOID LEUKEMIA IN CHRONIC PHASE (CML-CP) |
| title_short | P688: ASC2ESCALATE: A US PHASE 2, OPEN-LABEL, SINGLE-ARM, DOSE-ESCALATION STUDY OF ASCIMINIB MONOTHERAPY IN 2ND-LINE (2L) TREATMENT OF PATIENTS (PTS) WITH CHRONIC MYELOID LEUKEMIA IN CHRONIC PHASE (CML-CP) |
| title_sort | p688: asc2escalate: a us phase 2, open-label, single-arm, dose-escalation study of asciminib monotherapy in 2nd-line (2l) treatment of patients (pts) with chronic myeloid leukemia in chronic phase (cml-cp) |
| topic | Posters |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10428989/ http://dx.doi.org/10.1097/01.HS9.0000969656.81442.84 |
| work_keys_str_mv | AT atallahehab p688asc2escalateausphase2openlabelsinglearmdoseescalationstudyofasciminibmonotherapyin2ndline2ltreatmentofpatientsptswithchronicmyeloidleukemiainchronicphasecmlcp AT mauromichael p688asc2escalateausphase2openlabelsinglearmdoseescalationstudyofasciminibmonotherapyin2ndline2ltreatmentofpatientsptswithchronicmyeloidleukemiainchronicphasecmlcp AT sasakikoji p688asc2escalateausphase2openlabelsinglearmdoseescalationstudyofasciminibmonotherapyin2ndline2ltreatmentofpatientsptswithchronicmyeloidleukemiainchronicphasecmlcp AT yairlevymoshe p688asc2escalateausphase2openlabelsinglearmdoseescalationstudyofasciminibmonotherapyin2ndline2ltreatmentofpatientsptswithchronicmyeloidleukemiainchronicphasecmlcp AT kollerpaul p688asc2escalateausphase2openlabelsinglearmdoseescalationstudyofasciminibmonotherapyin2ndline2ltreatmentofpatientsptswithchronicmyeloidleukemiainchronicphasecmlcp AT sadekislam p688asc2escalateausphase2openlabelsinglearmdoseescalationstudyofasciminibmonotherapyin2ndline2ltreatmentofpatientsptswithchronicmyeloidleukemiainchronicphasecmlcp AT yangdaisy p688asc2escalateausphase2openlabelsinglearmdoseescalationstudyofasciminibmonotherapyin2ndline2ltreatmentofpatientsptswithchronicmyeloidleukemiainchronicphasecmlcp AT ruckelkumarjulie p688asc2escalateausphase2openlabelsinglearmdoseescalationstudyofasciminibmonotherapyin2ndline2ltreatmentofpatientsptswithchronicmyeloidleukemiainchronicphasecmlcp AT khanmahmudul p688asc2escalateausphase2openlabelsinglearmdoseescalationstudyofasciminibmonotherapyin2ndline2ltreatmentofpatientsptswithchronicmyeloidleukemiainchronicphasecmlcp AT cortesjorge p688asc2escalateausphase2openlabelsinglearmdoseescalationstudyofasciminibmonotherapyin2ndline2ltreatmentofpatientsptswithchronicmyeloidleukemiainchronicphasecmlcp |